Session Details

[F2]Flash Talks II

Tue. Aug 25, 2026 4:30 PM - 5:00 PM JST
Tue. Aug 25, 2026 7:30 AM - 8:00 AM UTC
Noh Theater (1F)

[F2-01]Preparation of Zn and ZnO targets for copper radionuclide production

*Alisa Paterson1, Lava Kumar Pillari2, Joe Singh1, Lukas Bichler2, Dale Schick-Martin1 (1. Sylvia Fedoruk Canadian Centre for Nuclear Innovation (Canada), 2. University of British Columbia-Okanagan (Canada))

[F2-02]Material characterization and CF4 treatment of SiC for target development at ISOL@MYRRHA and CERN-ISOLDE

*Flavia Guidubaldi1,2, Donald Houngbo1, Simon Stegmann3, João Pedro Ramos1, Matthias Alexander Grasser3, Thomas Elias Cocolios2, Lucia Popescu1 (1. SCK CEN - Belgian Nuclear Research Center (Belgium), 2. KU Leuven University (Belgium), 3. CERN - European Organization for Nuclear Research (Switzerland))

[F2-03]Optimisation in the Face of Limitations: Improving Solid Target Copper-64 Production Yields

Harris Panopoulos1, *Artur Konrad Cichocki1, Nathan Sonnberger1, Talia Enright1, Stan Poniger2, Stuart McCluskey1, Andrew Scott1 (1. Austin Health (Australia), 2. IPHASE technologies Pty Ltd (Australia))

[F2-04]Development of Solid Target Radiometal Production on a Retrofitted Alceo 4.0 System Integrated with an 18 MeV IBA Cyclone

*Arif Gulzar1, Damion Stimson1, Christoph Barkhausen1, Elizbeth Genik1, Carl Dixon1, Donald Maillet1, Kristofer J Thurecht1 (1. The University of Queensland (Australia))

[F2-05]Preparation of Clinical Grade [89Zr]Zr-DFO-Trastuzumab Using an Indigenously developed Solid Target System at PETtrace-800

*Kanchan Kushwaha1,2, Sudeep Kumar Sahu1, Arpit Mitra3, Sutapa Rakshit1, Rahul Bhoite1, Avik Chakraborty1, Nawab Singh Baghel1, Sharmila Banerjee1,2 (1. Bhabha Atomic Research Centre (India), 2. Homi Bhabha National Institute (India), 3. Board of Radiation and Isotope Technology (India))

[F2-06]Optimized degrader system for solid target station

*Ondrej Szöllős1, Marek Leporis1, Matúš Mozolík1 (1. BIONT, a.s., Bratislava (Slovakia))

[F2-07]Development of Liquid Target Systems for Radiometal Production on 16.5 MeV Biomedical Cyclotrons: 68Ga, 61Cu & 89Zr

*Germán Alfredo Falasco1, Leandro Urrutia1, Kevin Zirbesegger1, Juan Vázquez1, Andrea Paolino1, Andrés Blengio1, Javier Cabillón1, Alarico Rodríguez1, Francisco Alves2, Andrés Arazi3, Javier Giglio1, Eduardo Savio1 (1. Centro Uruguayo de Imagenología Molecular (Uruguay), 2. Instituto de Ciências Nucleares Aplicadas à Saúde (Portugal), 3. Comisión Nacional de Energía Atómica (Argentine))

[F2-08]Development of a Liquid Target System for Cyclotron-Based Production of Actinium-225

*Seyoung Oh1, Sang Chul Mun1, Kyo Chul Lee1, Seung Pyo Hong1 (1. Korea Institute of Radiological & Medical Sciences(KIRAMS) (Korea))

[F2-09]Cyclotron production of actinium-225 at NPI CAS

*Jan Ráliš1, Pavel Bartl1, Jan Klouda1, Kateřina Ondrák Fialová1, Lukáš Ondrák1, Ondřej Lebeda1 (1. Nuclear Physics Institute of the Czech Academy of Sciences, Řež, Czech Republic (Czech Republic))

[F2-10]Production and Purification of 203Pb from natTl Target

*Hiroki Aoto1, Terumi Yokoyama1, Eishun Kawagishi1, Atsushi Toyoshima1, Masashi Murakami1, Yukiyoshi Kon1, Masashi Kaneko1, Hiroyuki Kazama1, Yi Ka Hui1, Yoshitaka Kasamatsu1 (1. The University of Osaka (Japan))

[F2-11]Solid target Methodology for production of metallic radio-nuclides such as 64Cu, 89Zr & 124I, 68Ga via 18Mev Cyclotron and their applications as PET tracers

*Manish dixit1 (1. Sanjay Gandhi postgraduate institute of medical sciences (India))

[F2-12]High Purity Copper and Potassium Bromide Neutron Irradiations to Produce Short-Lived Radioisotopes

*Mathew Snow1, Justin Cooper1, Kolby Olney1, Tommy Holschuh1, Leah Squires1 (1. Idaho National Laboratory (USA))

[F2-13]Production of the theranostic 47Sc: Comparison between charged particles induced reactions

*Liliana Mou1, Sara Cisternino1, Lucia De Dominicis2, Laura De Nardo2, Juan Esposito1, Alisa Kotliarenko1, Laura Meléndez-Alafort3, Gaia Pupillo1 (1. National Institute of Nuclear Physics, Legnaro National Laboratories (INFN-LNL) (Italy), 2. Physics and Astronomy Department, Padova University (Italy), 3. Immunology and Molecular Oncology Diagnostics Unit, Veneto Institute of Oncology IOV-IRCCS (Italy))

[F2-14]Development of high-current normal- and oblique-incidence shuttles for radionuclide production at the IBA Cyclone 30XP using CFD and FEA

*Tobias Wachten1, Swen Humpert1, Stefan Spellerberg1, Bernd Neumaier1,2 (1. Forschungszentrum Jülich GmbH, Institute of Neurosciences and Medicine, Nuclear Chemistry (INM-5), Wilhelm-Johnen-Str., 52428 Jülich, Germany (Germany), 2. Institute of Radiochemistry and Experimental Molecular Imaging, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany (Germany))

[F2-15]The target laboratory at GSI/FAIR

*Noemi Cerboni1, Annett Huebner1, Diana Khropost1, Birgit Kindler1, Bettina Lommel1, Anita Reckziegel1, Jutta Steiner1 (1. GSI Helmholtzzentrum für Schwerionenforschung GmbH (Germany))

[F2-16]Establishing the CC-30/15 Cyclotron Facility at TINT: A Multipurpose Hub for Advanced Radioisotope Production and Ion Beam Applications in Thailand

*akkapob ngamlamiad1, Sarinrat Wonglee1, Boon-Uma Jowanaridhi1, Thanete Doungta1 (1. Thailand Institute of Nuclear Technology (Public Organization) (Thailand))

[F2-17]From One Vault to Another: The Epic Relocation of an IBA Cyclone 18/9

*Antje Uhlending1, Dean Jolly2, Luis F. Metello2, Viplav Gupta3, Verena Hugenberg1 (1. Heart and Diabetes Center, Bad Oeynhausen (Germany), 2. CYCLOTech - TERinov, Azores (Portugal), 3. German Cancer Research Center, Heidelberg (Germany))

[F2-18]Impact of Stable Target Mass on Metal Ion Extraction by Eichrom Resins

*Madeleine Anne Eddy1, Daniel McAlister1 (1. Eichrom Technologies (USA))

[F2-19]Fully automated and simultaneous production of [89Zr]Zr-Oxalate and [89Zr]Zr-Chloride based on two different processes

*Patrice Marchand1, Guilhem Claude2, Nathalie Dick1, Thierry Foehrenbacher1, Jacky Schuler1, Lucie Lorusso1, Michel Pellicioli1 (1. CNRS IPHC UMR 7178 (France), 2. Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Klinik für Nuklearmedizin, Radiopharmazie (Germany))

[F2-20]Development of the NuS-Alpha system for integrated alpha-emitter analysis

*mariko segawa1, Ichiro Nishinaka2, Makoto Maeda1, Yosuke Toh1, Naoyuki Ukon3, Kohshin Washiyama3 (1. Japan Atomic Energy Agency (Japan), 2. National Institutes for Quantum Science and Technology (Japan), 3. Fukushima Medical University (Japan))

[F2-21]Progress towards establishing regular production of 197m/gHg for applications in targeted Auger electron therapy (TAET)

*Yumeela Ganga-Sah1,2, Shaohuang Chen1,2, Patrick Davey1,2, Marianna Tosato1,2, Neil Weatherall1, Arjun Khalon1, Julius Balatoni1, Jordanne Burgess1,2, Daniel McAlister3, Madeleine Eddy3, Magdalena Gumiela4, Etienne Nigron4, Ferid Haddad4,5, Anne-Cécile Bonraisin4, Madeline Brown6, Arthur Chu6, Zhongli Cai6, Raymond Reilly6, Caterina Ramogida1,2, Valery Radchenko1,7 (1. TRIUMF (Canada), 2. Simon Fraser University (Canada), 3. Eichrom Technologies LLC (USA), 4. ARRONAX GIP (France), 5. Laboratoire SUBATECH (France), 6. University of Toronto (Canada), 7. University of British Columbia (Canada))

[F2-22][18F]FDG-Fluorescent glucose pair for translation of PET derived metabolic information to real time visualisation during surgical therapy

*Aarti Aggarwal1, Amit Sharma2, Sejal Chopra1, Bhabani Shanker Mohanty3, Pradip Chaudhari3, Jaya Shukla1 (1. Dept. of Nuclear Medicine, Post Graduate Institute of Medical Education & Research (India), 2. Amity School of Chemical Sciences, Amity University (India), 3. Translational Preclinical Imaging and Radiotherapy Facility, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Tata Memorial Centre (India))

Time Adjustment